Krystal Biotech KRYS
NASDAQ KRYS
$325.31 -7.25 (-2.18%)
At close: Oct 1, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Long-Term Deferred Tax (2025 - 2026)

Updated

Krystal Biotech (KRYS) recorded Long-Term Deferred Tax of $22.82 million in Q2 2026, unchanged from the prior quarter.

Analysis

Krystal Biotech (KRYS) Long-Term Deferred Tax (2025 - 2026) Analysis & Trends

Starting with Q3 2025, Krystal Biotech's Long-Term Deferred Tax history includes 4 quarters.

  • Quarterly Long-Term Deferred Tax has ranged from $22.82 million in Q4 2025 to $24.68 million in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $22.82 million (Q1 2026), $22.82 million (Q4 2025) and $24.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.82 Mn
Mar 31, 2026 22.82 Mn
Dec 31, 2025 22.82 Mn
Sep 30, 2025 24.68 Mn
API Access

Krystal Biotech Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=KRYS&period=max&api_key=YOUR_API_KEY